Intraocular Lens Market Regional Analysis:
North America Market Insights
The intraocular lens market in North America is projected to witness growth by the end of 2035, backed by growing healthcare investment and the rising prevalence of cataracts. IOLs and cataract surgery are usually covered by favorable reimbursement rules in North America, which has expanded the use of premium IOLs among patients and medical professionals.
According to the Centers for Medicare & Medicaid Services in December 2024, U.S. healthcare spending grew 7.5% in 2023, reaching USD 4.9 trillion or USD 14,570 per person. In the country, minimally invasive surgery methods such as femtosecond laser-assisted cataract surgery (FLACS) and microincision cataract surgery (MICS) are becoming common.
Europe Market Insights
The Europe intraocular lens market is estimated to be the second-largest due to the presence of aging in the European population. Age-related clouding of the natural lens of the eye could lead to cataracts, which could impair vision. Europe is home to a large number of creative businesses and research organizations that are creating new and sophisticated IOLs. Patients and surgeons are turning to these new technologies to get better visual results, which is propelling market expansion. According to the government of the UK in the financial year 2022, there were over 409,000 admissions to hospitals for cataract surgery in England.
Asia Pacific Market Insights
The intraocular lens market in the Asia Pacific is also estimated to have significant growth over the forecast period. Eye conditions including cataracts, diabetic retinopathy, and age-related macular degeneration are very common. Many nations in the Asia-Pacific are well-liked spots for medical tourism, particularly for eye surgery. Moreover, the insurance coverage for cataract surgery and IOLs is expanding in several nations around the Asia-Pacific.
